C509-0037 Screening compound: 1-[3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carbonyl]-4-(2-methoxyphenyl)piperazine

C509-0037 Screening compound: 1-[3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carbonyl]-4-(2-methoxyphenyl)piperazine
C509-0037 Screening compound: 1-[3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carbonyl]-4-(2-methoxyphenyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound C509-0037
1-[3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carbonyl]-4-(2-methoxyphenyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C509-0037

Molecular Formula

C24H23ClN4O2S (C24 H23 ClN4 O2 S)

Compound Name

1-[3-(4-chlorophenyl)-1-methyl-1H-thieno[2,3-c]pyrazole-5-carbonyl]-4-(2-methoxyphenyl)piperazine

IUPAC name

1-[3-(4-chlorophenyl)-1-methyl-1H-thieno[23-c]pyrazole-5-carbonyl]-4-(2-methoxyphenyl)piperazine

SMILES

Cn(c1c2cc(C(N(CC3)CCN3c(cccc3)c3OC)=O)s1)nc2-c(cc1)ccc1Cl

InChI

InChI=1S/C24H23ClN4O2S/c1-27-24-18(22(26-27)16-7-9-17(25)10-8-16)15-21(32-24)23(30)29-13-11-28(12-14-29)19-5-3-4-6-20(19)31-2/h3-10,15H,11-14H2,1-2H3

InChI Key

YVXABMGBGJSETK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14762930

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

466.99

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.739

Distribution Coefficient, logD

4.739

Water Solubility, LogSw

-4.91

Polar Surface Area

42.594

Acid Dissociation Constant (pKa)

28.47

Base Dissociation Constant (pKb)

3.35

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

C509-0037 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C509-0037 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C509-0037?
Check Price and Availability of C509-0037, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C509-0037 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C509-0037
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C509-0037
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C509-0037 available by request